EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Before–After Study of Gastrodia elata Blume-Based Nutraceutical Supplementation in Patients with Radiculopathy and Carpal Tunnel Syndrome

Marco Invernizzi iD, Lorenzo Lippi iD, Simone Mulè, Rebecca Galla, Arianna Folli iD, Domenico Tiso iD, Francesca Parini iD, Francesca Uberti iD

Nutrients · 2026

DOI: 10.3390/nu18091438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Marco Invernizzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Piemonte Orientale (UPO), 28100 Novara, Italy. Hauptthemen laut MEDLINE: Carpal Tunnel Syndrome, Dietary Supplements, Radiculopathy, Gastrodia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agave Group srl, Noivita Srls.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cervical and lumbar radiculopathy and carpal tunnel syndrome (CTS) are common conditions that are associated with persistent pain, functional impairment, and reduced quality of life. Nutraceutical strategies targeting neuroinflammatory and oxidative stress pathways are being investigated as adjunctive approaches in pain management. This study evaluated the clinical association between supplementation with a Gastrodiae elata Blume-based nutraceutical formulation (Assonal®) and changes in pain intensity, functional outcomes, symptom burden, and quality of life in patients with radiculopathy and CTS.

Methods

A single-centre pragmatic before–after clinical study enrolled adults with cervical or lumbar radiculopathy and/or CTS. Participants received Assonal® (two tablets daily) for two months. Pain intensity was assessed using the Numerical Pain Rating Scale (NPRS) and Visual Analogue Scale (VAS). Secondary outcomes included the Back Pain Functional Scale (BPFS), the Boston Carpal Tunnel Questionnaire (BCTQ), the Neuropathic Pain Symptom Inventory (NPSI), the EuroQol-5D-5L (EQ-5D-5L), and the Global Perceived Effect (GPE). Longitudinal within-subject changes were analysed using repeated-measures statistical tests.

Results

Thirty-four participants completed the study. The observed pain intensity decreased significantly from baseline to two months (NPRS: 7.2 ± 1.3 to 3.6 ± 1.2; VAS: 7.3 ± 2.1 to 3.3 ± 1.7; p < 0.0001) and functional measures showed improvements across BPFS and BCTQ assessments, accompanied by reductions in symptom burden (NPSI). Quality of life increased significantly (EQ-5D-5L index: 0.49 ± 0.23 to 0.81 ± 0.12; p < 0.0001), and most patients reported perceived clinical improvement.

Conclusions

In this exploratory real-world study, Assonal® supplementation was associated with clinically relevant improvements in pain intensity, functional performance, and quality of life in patients with radiculopathy and CTS, suggesting the need for further investigation of these associations in future controlled clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carpal Tunnel SyndromeDietary SupplementsRadiculopathyGastrodiaHumansFemaleMiddle AgedMaleQuality of LifeAdultTreatment OutcomePain MeasurementAged

Stichwörter der Autor:innen

Gastrodia elata Blumecarpal tunnel syndromefunctional outcomesnutraceutical supplementationradiculopathyreal-world clinical study

Autor:innen und Institutionen

  • Department of Health Sciences, University of Piemonte Orientale (UPO), 28100 Novara, Italy.
  • Translational Medicine, Dipartimento Attività Integrate Ricerca e Innovazione (DAIRI), Azienda Ospedaliero-Universitaria (AOU) SS, Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.
  • Department for Sustainable Development and Ecological Transition, University of Piemonte Orientale (UPO), Piazza Sant'Eusebio 5, 13100 Vercelli, Italy.
  • Noivita Srls, Spin-Off University of Piemonte Orientale, Strada Privata Curti 7, 28100 Novara, Italy.
  • Department of Clinical Nutrition, "Villa Maria" Hospital, 47921 Rimini, Italy.

ORCID-Profile: Marco Invernizzi, Lorenzo Lippi, Arianna Folli, Domenico Tiso, Francesca Parini, Francesca Uberti

Förderung

  • Agave Group srl
  • Noivita Srls

Zitieren

APA

Invernizzi, M., Lippi, L., Mulè, S., Galla, R., Folli, A., Tiso, D., Parini, F., & Uberti, F. (2026). Real-World Before–After Study of Gastrodia elata Blume-Based Nutraceutical Supplementation in Patients with Radiculopathy and Carpal Tunnel Syndrome. Nutrients. https://doi.org/10.3390/nu18091438

Vancouver

Invernizzi M, Lippi L, Mulè S, Galla R, Folli A, Tiso D, et al. Real-World Before–After Study of Gastrodia elata Blume-Based Nutraceutical Supplementation in Patients with Radiculopathy and Carpal Tunnel Syndrome. Nutrients. 2026. doi:10.3390/nu18091438

BibTeX
@article{Invernizzi2026,
  author = {Invernizzi, Marco and Lippi, Lorenzo and Mulè, Simone and Galla, Rebecca and Folli, Arianna and Tiso, Domenico and Parini, Francesca and Uberti, Francesca},
  title = {Real-World Before–After Study of Gastrodia elata Blume-Based Nutraceutical Supplementation in Patients with Radiculopathy and Carpal Tunnel Syndrome},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18091438}
}
Kostenlos starten →